Axicabtagene ciloleucel for treating diffuse large B-cell lymphoma, mediastinal B-cell lymphoma and follicular lymphoma.: Single Technology Appraisal Evidence Assessment Group report

Mark Stephen Corbett; Ana Isabel Duarte; Hollie Anne Melton; Simon Mark Walker; Kath Wright; Alison Jane Eastwood; Stephen John Palmer

Axicabtagene ciloleucel for treating diffuse large B-cell lymphoma, mediastinal B-cell lymphoma and follicular lymphoma. Single Technology Appraisal Evidence Assessment Group report

Mark Stephen Corbett, Ana Isabel Duarte, Hollie Anne Melton, Simon Mark Walker, Kath Wright, Alison Jane Eastwood, Stephen John Palmer

Research output: Book/Report › Commissioned report

Original language	English
Commissioning body	National Institute for Health and Care Excellence
Number of pages	674
Publication status	Published - 2018

Access to Document

https://www.nice.org.uk/guidance/gid-ta10214/documents/committee-papers

Cite this

@book{b7c64c760aca4010bf60fad1cda07bc0,

title = "Axicabtagene ciloleucel for treating diffuse large B-cell lymphoma, mediastinal B-cell lymphoma and follicular lymphoma.: Single Technology Appraisal Evidence Assessment Group report",

author = "Corbett, {Mark Stephen} and Duarte, {Ana Isabel} and Melton, {Hollie Anne} and Walker, {Simon Mark} and Kath Wright and Eastwood, {Alison Jane} and Palmer, {Stephen John}",

year = "2018",

language = "English",

}

TY - BOOK

T1 - Axicabtagene ciloleucel for treating diffuse large B-cell lymphoma, mediastinal B-cell lymphoma and follicular lymphoma.

T2 - Single Technology Appraisal Evidence Assessment Group report

AU - Corbett, Mark Stephen

AU - Duarte, Ana Isabel

AU - Melton, Hollie Anne

AU - Walker, Simon Mark

AU - Wright, Kath

AU - Eastwood, Alison Jane

AU - Palmer, Stephen John

PY - 2018

Y1 - 2018

M3 - Commissioned report

BT - Axicabtagene ciloleucel for treating diffuse large B-cell lymphoma, mediastinal B-cell lymphoma and follicular lymphoma.

ER -